Your browser is no longer supported. Please, upgrade your browser.
Settings
COO The Cooper Companies, Inc. daily Stock Chart
COO [NYSE]
The Cooper Companies, Inc.
IndexS&P 500 P/E62.26 EPS (ttm)5.47 Insider Own0.20% Shs Outstand49.10M Perf Week2.55%
Market Cap17.55B Forward P/E27.09 EPS next Y12.58 Insider Trans-5.54% Shs Float48.73M Perf Month2.14%
Income272.40M PEG6.23 EPS next Q3.10 Inst Own91.70% Short Float1.28% Perf Quarter7.86%
Sales2.44B P/S7.19 EPS this Y29.20% Inst Trans0.72% Short Ratio2.42 Perf Half Y8.10%
Book/sh76.58 P/B4.45 EPS next Y31.46% ROA4.30% Target Price344.58 Perf Year7.49%
Cash/sh2.47 P/C137.75 EPS next 5Y10.00% ROE7.50% 52W Range236.68 - 371.59 Perf YTD6.04%
Dividend0.06 P/FCF98.32 EPS past 5Y10.80% ROI9.70% 52W High-8.31% Beta0.80
Dividend %0.02% Quick Ratio0.60 Sales past 5Y9.10% Gross Margin64.10% 52W Low43.96% ATR9.54
Employees12000 Current Ratio1.20 Sales Q/Q-14.90% Oper. Margin14.70% RSI (14)54.55 Volatility2.84% 2.78%
OptionableYes Debt/Eq0.50 EPS Q/Q-53.50% Profit Margin11.40% Rel Volume0.70 Prev Close329.01
ShortableYes LT Debt/Eq0.35 EarningsDec 03 AMC Payout1.10% Avg Volume259.15K Price340.71
Recom2.40 SMA202.38% SMA500.12% SMA2009.65% Volume182,485 Change3.56%
Jul-06-20Downgrade Robert W. Baird Outperform → Neutral $291
Mar-05-20Initiated Citigroup Neutral $360
Feb-01-19Upgrade Stephens Equal-Weight → Overweight $305
Jan-04-19Downgrade Goldman Neutral → Sell
Jul-30-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Apr-04-18Initiated Goldman Neutral $231
Dec-08-17Reiterated Stifel Buy $275 → $265
Sep-12-17Reiterated Stifel Buy $265 → $275
Sep-01-17Reiterated Piper Jaffray Overweight $265 → $280
Jul-21-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Jun-29-17Initiated Guggenheim Neutral
Jun-02-17Reiterated Stifel Buy $220 → $231
Dec-12-16Upgrade Wells Fargo Market Perform → Outperform
Sep-02-16Reiterated BMO Capital Markets Outperform $199 → $206
Aug-31-16Reiterated Stifel Buy $195 → $215
Jun-30-16Reiterated Stifel Buy $180 → $195
Jun-03-16Reiterated Jefferies Buy $175 → $190
Apr-15-16Upgrade Jefferies Hold → Buy
Dec-17-15Initiated Goldman Neutral
Dec-04-15Downgrade JP Morgan Overweight → Neutral
Nov-26-20 12:30PM  
08:58AM  
12:06AM  
Nov-24-20 08:21AM  
Nov-12-20 04:15PM  
Nov-10-20 09:23AM  
08:00AM  
Nov-03-20 04:15PM  
Oct-27-20 07:59AM  
Oct-19-20 02:11PM  
Oct-09-20 08:00AM  
Oct-03-20 11:30AM  
Oct-01-20 07:50AM  
Sep-21-20 03:02PM  
06:47AM  
Sep-14-20 10:02AM  
Sep-12-20 07:28AM  
Sep-10-20 07:15AM  
Sep-08-20 08:33AM  
Sep-07-20 02:03AM  
Sep-05-20 10:50AM  
Sep-04-20 03:50PM  
07:29AM  
06:31AM  
Sep-03-20 05:11PM  
04:15PM  
Sep-02-20 10:13AM  
Aug-31-20 04:15PM  
03:01PM  
08:15AM  
Aug-26-20 12:30PM  
Aug-24-20 11:20AM  
Aug-19-20 04:15PM  
Aug-13-20 04:15PM  
Aug-06-20 04:15PM  
Aug-05-20 11:40AM  
Jul-20-20 04:02PM  
Jul-11-20 03:46PM  
Jul-09-20 04:15PM  
Jul-06-20 04:15PM  
Jul-02-20 09:34AM  
Jun-30-20 12:56PM  
Jun-25-20 08:13AM  
Jun-15-20 11:11AM  
Jun-09-20 05:06PM  
Jun-05-20 12:02PM  
10:42AM  
01:00AM  
Jun-04-20 05:35PM  
04:15PM  
03:00PM  
Jun-01-20 09:52AM  
May-28-20 01:33PM  
12:30PM  
May-14-20 07:30AM  
May-07-20 04:15PM  
Apr-21-20 02:02PM  
Apr-13-20 09:45AM  
09:42AM  
Apr-09-20 07:28AM  
Apr-04-20 11:30AM  
Apr-03-20 11:40AM  
Apr-01-20 04:15PM  
Mar-30-20 06:32AM  
Mar-18-20 11:40AM  
Mar-17-20 09:20PM  
Mar-13-20 09:49AM  
Mar-09-20 06:55PM  
12:03PM  
Mar-06-20 09:53AM  
Mar-05-20 05:35PM  
04:15PM  
03:00PM  
Mar-03-20 09:26AM  
Feb-27-20 01:04PM  
12:30PM  
Feb-26-20 12:10PM  
Feb-24-20 09:36AM  
Feb-18-20 04:15PM  
Feb-12-20 04:15PM  
Feb-11-20 04:15PM  
Feb-07-20 04:15PM  
Feb-04-20 04:15PM  
Jan-29-20 06:32AM  
Jan-09-20 04:20PM  
12:27PM  
Jan-07-20 04:15PM  
Jan-04-20 11:30AM  
Jan-03-20 07:13AM  
Dec-19-19 04:15PM  
Dec-12-19 12:03AM  
Dec-09-19 04:15PM  
Dec-08-19 08:29AM  
Dec-06-19 08:21AM  
Dec-05-19 05:35PM  
04:15PM  
03:44PM  
Dec-03-19 08:24AM  
07:25AM  
Dec-02-19 09:40AM  
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Auerbach Robert DSpecial Advisor to the CEOOct 08Sale350.002,538888,3001,403Oct 09 08:26 PM
PETERSMEYER GARY SDirectorOct 06Option Exercise162.691,000162,6902,338Oct 07 05:06 PM
PETERSMEYER GARY SDirectorOct 06Sale348.541,000348,5401,338Oct 07 05:06 PM
Lindell Jody SDirectorSep 16Option Exercise66.806,500434,20019,054Sep 17 05:21 PM
Lindell Jody SDirectorSep 16Sale338.696,5002,201,45312,554Sep 17 05:21 PM
White Albert G IIIPresident & CEOJul 08Buy278.231,000278,23041,430Jul 08 04:58 PM
Sheffield Holly REVP, CSOJul 08Buy280.20534149,6241,414Jul 08 04:57 PM
Sheffield Holly REVP, CSOJul 08Buy280.0035599,4001,285Jul 08 04:57 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJul 01Option Exercise0.0034802,148Jul 02 05:45 PM
Sheffield Holly REVP, CSOJun 12Buy283.18880249,198880Jun 15 04:43 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJun 11Buy281.471,000281,4701,800Jun 15 04:39 PM
Sheffield Holly REVP, CSOJun 04Option Exercise0.001,10501,383Jun 08 04:30 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffFeb 03Option Exercise0.0055501,057Feb 04 04:59 PM
Golden RandalVP, General Counsel & Sec.Feb 03Option Exercise0.0061001,995Feb 04 04:58 PM
Auerbach Robert DPresident, CSIFeb 03Option Exercise0.0066604,582Feb 04 04:47 PM
Andrews Brian GSVP, CFO & TreasurerFeb 03Option Exercise0.0055501,935Feb 04 04:46 PM
Auerbach Robert DPresident, CSIJan 08Option Exercise0.001,90703,723Jan 10 06:15 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJan 08Option Exercise0.001,0650637Jan 10 06:15 PM
Andrews Brian GSVP, CFO & TreasurerJan 08Option Exercise0.0059501,438Jan 10 06:12 PM
Golden RandalVP, General Counsel & Sec.Jan 08Option Exercise0.0050201,520Jan 10 06:13 PM
Sheffield Holly REVP, CSOJan 08Option Exercise0.005890589Jan 10 06:11 PM
White Albert G IIIPresident & CEOJan 08Option Exercise0.00452039,454Jan 10 06:10 PM
McBride Daniel GEVP, COO & Pres-CooperVisionJan 08Option Exercise0.00708031,395Jan 10 06:09 PM
Lindell Jody SDirectorJan 06Option Exercise49.573,500173,49516,054Jan 07 04:57 PM
Lindell Jody SDirectorJan 06Sale321.013,5001,123,53412,554Jan 07 04:57 PM
PETERSMEYER GARY SDirectorJan 06Sale322.2925080,5731,338Jan 07 04:54 PM
KALKSTEIN MICHAELDirectorJan 02Option Exercise61.369,500582,91012,338Jan 06 05:44 PM
KALKSTEIN MICHAELDirectorJan 02Sale320.359,5003,043,3195,838Jan 06 05:44 PM
STAA STAAR Surgical Company daily Stock Chart
STAA [NASD]
STAAR Surgical Company
Index- P/E388.72 EPS (ttm)0.19 Insider Own0.50% Shs Outstand45.90M Perf Week-10.90%
Market Cap3.22B Forward P/E207.61 EPS next Y0.35 Insider Trans-57.61% Shs Float45.57M Perf Month0.00%
Income9.00M PEG12.96 EPS next Q0.02 Inst Own88.60% Short Float5.32% Perf Quarter60.09%
Sales156.30M P/S20.61 EPS this Y172.90% Inst Trans-6.76% Short Ratio4.59 Perf Half Y83.94%
Book/sh4.06 P/B18.00 EPS next Y329.27% ROA4.10% Target Price79.60 Perf Year98.10%
Cash/sh2.91 P/C25.11 EPS next 5Y30.00% ROE5.20% 52W Range23.20 - 85.63 Perf YTD107.79%
Dividend- P/FCF1610.68 EPS past 5Y27.40% ROI7.90% 52W High-14.66% Beta1.09
Dividend %- Quick Ratio5.30 Sales past 5Y14.90% Gross Margin72.20% 52W Low215.00% ATR4.55
Employees550 Current Ratio5.80 Sales Q/Q20.50% Oper. Margin3.30% RSI (14)47.71 Volatility7.02% 6.26%
OptionableYes Debt/Eq0.01 EPS Q/Q58.50% Profit Margin5.70% Rel Volume0.66 Prev Close69.87
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout0.00% Avg Volume527.97K Price73.08
Recom1.70 SMA20-5.59% SMA508.21% SMA20048.36% Volume347,614 Change4.59%
Oct-26-20Downgrade Sidoti Buy → Neutral
Aug-31-20Upgrade Sidoti Neutral → Buy $58
Aug-06-20Reiterated The Benchmark Company Buy $50 → $66
Jul-06-20Downgrade Sidoti Buy → Neutral $58
Jun-24-20Downgrade BTIG Research Buy → Neutral
Jun-15-20Initiated Jefferies Buy $55
Dec-04-19Initiated BTIG Research Buy
Sep-24-18Reiterated The Benchmark Company Buy $45 → $54
Aug-06-18Resumed The Benchmark Company Buy $45
Nov-20-17Reiterated The Benchmark Company Buy $21
Aug-14-17Reiterated The Benchmark Company Buy $12 → $13
Mar-03-17Reiterated The Benchmark Company Buy $10 → $12
May-18-16Upgrade The Benchmark Company Hold → Buy $6
Sep-10-13Resumed The Benchmark Company Buy $15
Feb-28-13Reiterated The Benchmark Company Buy $10 → $6.50
Nov-01-12Downgrade Canaccord Genuity Buy → Hold $8.25 → $7
Mar-02-12Initiated Northland Securities Outperform $14
Oct-25-11Reiterated The Benchmark Company Buy $10 → $12.50
Oct-12-10Initiated Morgan Joseph Buy $6.40
May-11-10Initiated Benchmark Buy $7
Nov-09-20 02:57PM  
Nov-04-20 10:02PM  
05:35PM  
04:03PM  
04:01PM  
02:30PM  
Oct-28-20 12:32PM  
Oct-21-20 07:00AM  
Oct-19-20 03:09PM  
01:43PM  
12:35PM  
12:30PM  
12:11PM  
11:50AM  
11:30AM  
10:00AM  
09:53AM  
08:24AM  
08:02AM  
06:35AM  
Oct-18-20 10:45PM  
10:33AM  
08:00AM  
Oct-17-20 01:56PM  
11:10AM  
Oct-16-20 09:03PM  
04:55PM  
03:37PM  
02:44PM  
02:40PM  
02:01PM  
01:15PM  
11:15AM  
11:00AM  
10:45AM  
Oct-15-20 04:07PM  
02:41PM  
02:22PM  
11:30AM  
11:00AM  
10:51AM  
Oct-14-20 02:25PM  
02:10PM  
01:07PM  
11:30AM  
11:00AM  
11:00AM  
10:27AM  
Oct-13-20 08:28PM  
08:15PM  
06:00PM  
01:30PM  
12:00PM  
11:45AM  
11:15AM  
11:00AM  
10:24AM  
Oct-12-20 04:55PM  
04:30PM  
03:38PM  
02:50PM  
12:00PM  
12:00PM  
11:15AM  
11:00AM  
09:31AM  
08:00AM  
08:00AM  
06:20AM  
Oct-11-20 03:35PM  
10:35AM  
Oct-10-20 11:50PM  
02:43PM  
Oct-09-20 09:25PM  
07:53PM  
06:40PM  
05:50PM  
04:40PM  
01:30PM  
01:00PM  
11:29AM  
10:01AM  
06:21AM  
Oct-08-20 10:59PM  
09:17PM  
08:00PM  
06:36PM  
04:25PM  
12:30PM  
10:01AM  
10:00AM  
08:00AM  
06:57AM  
Oct-07-20 09:16PM  
06:51PM  
06:32PM  
02:00PM  
01:45PM  
01:45PM  
12:30PM  
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 23Option Exercise15.541,90029,526113,155Nov 23 04:51 PM
Francese James ESr. VP, Comm. Ops., NA, APACNov 23Option Exercise9.1418,959173,28870,342Nov 25 04:08 PM
Francese James ESr. VP, Comm. Ops., NA, APACNov 23Sale80.1318,9591,519,18551,383Nov 25 04:08 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 23Sale83.094,774396,682108,381Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 20Sale83.022,688223,158111,255Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 19Option Exercise15.5412,156188,904140,106Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 19Sale82.0314,0071,148,994113,943Nov 23 04:51 PM
Barnes Scott DChief Medical OfficerNov 16Option Exercise34.4922,593779,33942,983Nov 17 04:52 PM
Holliday KeithChief Technology OfficerNov 09Option Exercise8.2138,714317,82958,046Nov 12 04:50 PM
Moore John CDirectorNov 09Option Exercise14.0916,206228,32718,323Nov 12 04:48 PM
Hayashida Jon K.VP, Global Clinical, MedicalNov 09Option Exercise23.1120,000462,23030,794Nov 12 04:51 PM
Holliday KeithChief Technology OfficerNov 09Sale81.5623,7141,934,11434,332Nov 12 04:50 PM
Hayashida Jon K.VP, Global Clinical, MedicalNov 09Sale81.3420,0001,626,80010,794Nov 12 04:51 PM
Holliday KeithChief Technology OfficerSep 15Option Exercise27.0436,326982,42455,658Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 15Sale53.3336,3261,937,26619,332Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Option Exercise10.2426,574272,20855,021Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Sale53.3235,6891,902,89319,332Sep 16 06:01 PM
Moore John CDirectorSep 09Sale52.04137,3317,146,70521,387Sep 11 04:07 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Option Exercise10.1841,602423,69752,396Aug 12 06:30 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Sale51.2241,6022,130,85410,794Aug 12 06:30 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Option Exercise8.1139,215318,165167,165Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Sale44.0739,2151,728,205127,950Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Option Exercise11.007858,635128,735Jun 12 04:01 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Sale44.0078534,540127,950Jun 12 04:01 PM
Gesten Samuel JChief Legal OfficerMay 21Sale40.00192,5227,700,88041,185May 26 04:16 PM
Holliday KeithChief Technology OfficerMay 15Option Exercise7.2025,000180,00053,447May 15 06:10 PM
Holliday KeithChief Technology OfficerMay 15Sale37.6925,000942,25028,447May 15 06:10 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 13Option Exercise5.346,66735,60251,133May 13 06:49 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Option Exercise8.4846,563394,87957,357May 13 06:50 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Option Exercise13.6620,283277,01929,972May 13 06:48 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Option Exercise12.0718,856227,50263,322May 13 06:49 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Sale39.1146,5631,821,07910,794May 13 06:50 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Sale39.0618,856736,51544,466May 13 06:49 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Sale39.0218,189709,70816,022May 13 06:48 PM
Hayashida Jon K.VP, Global Clinical, MedicalMar 23Sale26.832,81375,47310,794Mar 24 04:18 PM
Hansen Graydon C.Sr. VP, Global OperationsMar 23Sale27.422,81377,13219,459Mar 24 04:16 PM
Gesten Samuel JChief Legal OfficerMar 23Sale27.422,74275,18641,185Mar 24 04:14 PM
Francese James ESr. VP, Comm. Ops., NA, APACMar 23Sale26.772,25060,23344,466Mar 24 04:13 PM
ANDREWS DEBORAH JChief Financial OfficerMar 23Sale27.4283422,86831,267Mar 24 04:09 PM
Moore John CDirectorMar 18Option Exercise5.8110,00058,10066,422Mar 19 04:15 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Option Exercise11.11106,6041,184,228138,705Jan 23 04:06 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Sale42.20106,6044,498,68932,101Jan 23 04:06 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Option Exercise8.6432,335279,37453,658Dec 06 04:35 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Sale37.2047,4081,763,6196,250Dec 06 04:35 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Option Exercise5.6045,000251,800149,200Dec 06 04:34 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Sale38.1545,0001,716,750124,200Dec 06 04:34 PM
EYE National Vision Holdings, Inc. daily Stock Chart
EYE [NASD]
National Vision Holdings, Inc.
Index- P/E1045.95 EPS (ttm)0.04 Insider Own0.40% Shs Outstand80.68M Perf Week3.98%
Market Cap3.59B Forward P/E49.81 EPS next Y0.88 Insider Trans-33.43% Shs Float80.24M Perf Month5.22%
Income5.10M PEG86.44 EPS next Q0.13 Inst Own- Short Float10.19% Perf Quarter18.12%
Sales1.62B P/S2.22 EPS this Y34.20% Inst Trans-0.10% Short Ratio13.34 Perf Half Y70.34%
Book/sh10.72 P/B4.10 EPS next Y59.21% ROA0.20% Target Price49.33 Perf Year44.84%
Cash/sh4.62 P/C9.52 EPS next 5Y12.10% ROE0.60% 52W Range11.70 - 50.00 Perf YTD35.46%
Dividend- P/FCF27.14 EPS past 5Y26.30% ROI4.90% 52W High-12.14% Beta-
Dividend %- Quick Ratio1.20 Sales past 5Y13.10% Gross Margin53.10% 52W Low275.47% ATR1.92
Employees11781 Current Ratio1.60 Sales Q/Q12.40% Oper. Margin2.40% RSI (14)53.70 Volatility4.15% 4.61%
OptionableYes Debt/Eq0.75 EPS Q/Q2860.50% Profit Margin0.30% Rel Volume0.33 Prev Close44.28
ShortableYes LT Debt/Eq0.75 EarningsNov 05 BMO Payout0.00% Avg Volume613.02K Price43.93
Recom1.80 SMA200.18% SMA505.74% SMA20034.63% Volume204,102 Change-0.79%
Nov-18-20Downgrade Berenberg Buy → Hold $42
Feb-04-20Initiated BMO Capital Markets Market Perform
Feb-03-20Initiated BMO Capital Markets Market Perform
Nov-13-19Initiated Barclays Overweight $34
Oct-01-19Upgrade BofA/Merrill Neutral → Buy
Aug-07-19Upgrade Loop Capital Hold → Buy $30 → $37
Jul-11-19Initiated Goldman Buy $33
Jun-14-19Initiated Loop Capital Hold
May-29-19Initiated Berenberg Buy
Oct-04-18Initiated William Blair Outperform
Oct-02-18Initiated Barclays Equal Weight $50
Apr-24-18Initiated Wells Fargo Outperform
Nov-09-20 10:17AM  
Nov-07-20 09:14AM  
Nov-05-20 11:31PM  
08:56AM  
08:35AM  
06:00AM  
Oct-30-20 11:59AM  
Oct-29-20 12:35PM  
Oct-26-20 04:30PM  
Oct-21-20 04:30PM  
Sep-29-20 09:00AM  
Sep-14-20 05:00PM  
09:24AM  
Sep-09-20 01:51PM  
Sep-05-20 11:31AM  
Sep-04-20 08:00AM  
Aug-21-20 08:24AM  
Aug-13-20 12:20PM  
Aug-12-20 09:54AM  
08:45AM  
Aug-06-20 08:05AM  
06:00AM  
Aug-05-20 08:33AM  
Jul-30-20 12:33PM  
Jul-23-20 06:00AM  
Jul-20-20 09:00AM  
Jul-16-20 09:00AM  
Jul-07-20 09:00AM  
Jul-01-20 01:00AM  
Jun-08-20 04:05PM  
Jun-03-20 08:00AM  
May-15-20 09:00AM  
May-12-20 10:00AM  
May-09-20 01:31PM  
May-07-20 07:46PM  
07:10AM  
07:00AM  
May-04-20 04:54PM  
Apr-23-20 06:56PM  
04:05PM  
Apr-21-20 12:03PM  
Apr-15-20 09:33AM  
08:57AM  
Apr-09-20 09:35AM  
Apr-08-20 09:12AM  
Apr-07-20 09:30AM  
09:18AM  
06:55AM  
Apr-02-20 04:05PM  
Mar-29-20 07:31PM  
Mar-27-20 01:30PM  
11:31AM  
04:00AM  
Mar-19-20 08:20AM  
Mar-18-20 04:57PM  
Mar-17-20 10:20AM  
07:03AM  
Mar-16-20 08:00AM  
Mar-13-20 10:03AM  
Mar-10-20 02:48PM  
Mar-04-20 09:02AM  
Mar-03-20 05:03PM  
08:00AM  
Feb-28-20 07:09AM  
Feb-26-20 06:00AM  
Feb-19-20 08:00AM  
Feb-10-20 08:00AM  
Feb-07-20 08:51AM  
Jan-07-20 07:53AM  
Jan-06-20 08:00AM  
Jan-02-20 09:40AM  
09:19AM  
09:14AM  
09:14AM  
Dec-30-19 10:17AM  
Dec-27-19 12:05PM  
Dec-24-19 11:21AM  
11:17AM  
09:26AM  
Dec-23-19 09:34AM  
09:15AM  
Dec-20-19 10:08AM  
Dec-19-19 11:40AM  
11:30AM  
08:58AM  
Dec-18-19 09:49AM  
Dec-16-19 11:26AM  
09:38AM  
09:28AM  
Dec-13-19 04:51AM  
Dec-12-19 06:39AM  
Dec-11-19 09:48AM  
Dec-10-19 10:04AM  
08:32AM  
07:36AM  
Dec-09-19 09:01AM  
08:58AM  
08:00AM  
Dec-07-19 06:07PM  
11:31AM  
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer primarily in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization, vision care benefit plan, and optometric services. As of December 28, 2019, the company operated through 1,151 retail stores in the United States and its territories, as well as various e-commerce Websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moore Patrick R.SVP, Chief Financial OfficerNov 09Option Exercise4.2758,161248,34762,661Nov 12 04:42 PM
Moore Patrick R.SVP, Chief Financial OfficerNov 09Sale47.1758,1612,743,4544,500Nov 12 04:42 PM
FAHS L READEChief Executive OfficerNov 05Sale43.80100,0004,380,000218,037Nov 09 04:50 PM
FAHS L READEChief Executive OfficerJan 23Sale36.5075,0002,737,500318,037Jan 27 04:15 PM
Moore Patrick R.SVP, Chief Financial OfficerDec 18Option Exercise4.2769,977298,80274,477Dec 19 04:35 PM
Moore Patrick R.SVP, Chief Financial OfficerDec 18Sale32.0069,9772,239,2644,500Dec 19 04:35 PM
Moore Patrick R.SVP, Chief Financial OfficerDec 17Option Exercise4.2723984,523Dec 19 04:35 PM
Moore Patrick R.SVP, Chief Financial OfficerDec 17Sale32.00237364,500Dec 19 04:35 PM